Who owns Morphosys Ag Adr?
- Ticker: MOR
- CUSIP Number: 617760202
Tip: Access positions for across all investors
Analyze quarterly positions in Morphosys with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Morphosys stock
Who bought or sold Morphosys Ag Adr this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Kynam Capital Management | 4.2M | $42M | 100% | Dec 2023 |
|
Point72 Asset Management | 3.8M | $38M | 2075% | Dec 2023 |
|
T. Rowe Price Associates | 2.7M | $27M | 100% | Dec 2023 |
|
Logos Global Management | 2.5M | $25M | 161% | Dec 2023 |
|
Caption Management | 419k | $4.1M | 100% | Dec 2023 |
|
Ikarian Capital | 400k | $4.0M | 100% | Dec 2023 |
|
TD Asset Management | 361k | $3.6M | 154% | Dec 2023 |
|
Citadel Advisors | 350k | $3.5M | 122% | Dec 2023 |
|
Millennium Management | 330k | $3.3M | 2036% | Dec 2023 |
|
Marshall Wace | 326k | $3.2M | 100% | Dec 2023 |
|
Goldman Sachs Group | 276k | $2.7M | 594% | Dec 2023 |
|
TIG Advisors | 245k | $2.4M | 100% | Dec 2023 |
|
Cubist Systematic Strategies | 196k | $1.9M | 682% | Dec 2023 |
|
Two Sigma Investments | 186k | $1.8M | 100% | Dec 2023 |
|
Opaleye Management | 145k | $1.4M | -88% | Dec 2023 |
|
Hennion & Walsh Asset Management | 117k | $2.1M | 71% | Mar 2024 |
|
Jane Street | 102k | $961k | 100% | Dec 2023 |
|
Gts Securities | 51k | $503k | 100% | Dec 2023 |
|
Henry James International Management | 43k | $426k | 100% | Dec 2023 |
|
Squarepoint Ops | 37k | $362k | 100% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 33k | $590k | 130% | Mar 2024 |
|
Two Sigma Advisers | 32k | $320k | 100% | Dec 2023 |
|
Balyasny Asset Management | 32k | $313k | 100% | Dec 2023 |
|
Virtu Financial | 25k | $244k | 100% | Dec 2023 |
|
Exchange Traded Concepts | 16k | $288k | -9% | Mar 2024 |
|
Cutler | 15k | $0 | -73% | Mar 2024 |
|
Bank of America Corporation | 5.6k | $55k | 30% | Dec 2023 |
|
Quadrant Capital | 5.6k | $55k | 205% | Dec 2023 |
|
Simplex Trading | 4.9k | $88k | -96% | Mar 2024 |
|
Rhumbline Advisers | 3.8k | $38k | 217% | Dec 2023 |
|
Wells Fargo & Company | 2.7k | $27k | -95% | Dec 2023 |
|
Signature | 2.6k | $26k | -2% | Dec 2023 |
|
GAMMA Investing | 1.9k | $35k | 24% | Mar 2024 |
|
Parallel Advisors | 1.5k | $15k | 339% | Dec 2023 |
|
Us Bancorp | 1.3k | $13k | 95% | Dec 2023 |
|
Lindbrook Capital | 1.2k | $23k | 8% | Mar 2024 |
|
UBS Group | 800.00 | $7.9k | -11% | Dec 2023 |
|
Nbc Securities | 695.00 | $12k | 0% | Mar 2024 |
|
Royal Bank of Canada | 200.00 | $2.0k | 0% | Dec 2023 |
|
Advisor Group Holdings | 9.00 | $89.000100 | -18% | Dec 2023 |
|
Who sold out of Morphosys?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Hudson Bay Capital Management | Sep 2023 | 455k | $3.1M |
AlphaCentric Advisors | Sep 2023 | 185k | $1.2M |
Jpmorgan Chase & Co | Sep 2023 | 40k | $267k |
Schonfeld Strategic Advisors | Sep 2023 | 28k | $186k |
Bell Investment Advisors | Sep 2023 | 160.00 | $1.1k |
Ronald Blue Trust | Dec 2023 | 39.00 | $0 |